H5N1 Flu Vaccine in Ferrets
Author Information
Author(s): Baras BenoƮt, Stittelaar Koert J., Simon James H., Thoolen Robert J. M. M., Mossman Sally P., Pistoor Frank H. M., van Amerongen Geert, Wettendorff Martine A., Hanon Emmanuel, Osterhaus Albert D. M. E.
Primary Institution: GlaxoSmithKline Biologicals
Hypothesis
Can an adjuvanted H5N1 vaccine induce cross-protection against different strains in ferrets?
Conclusion
The adjuvanted H5N1 candidate vaccine shows potential as an effective tool in pandemic preparedness.
Supporting Evidence
- Ferrets receiving the adjuvanted vaccine had a 96% survival rate after a lethal virus challenge.
- The vaccine induced neutralizing antibodies in 74% of ferrets against clade 1 and 61% against clade 2 viruses.
- Control groups receiving non-adjuvanted vaccine or adjuvant alone all died or were euthanized.
Takeaway
Researchers tested a flu vaccine on ferrets to see if it could protect them from a dangerous virus, and it worked really well!
Methodology
Ferrets were vaccinated with different doses of an adjuvanted H5N1 vaccine and then challenged with a lethal virus.
Limitations
The study was conducted in ferrets, which may not fully represent human responses.
Participant Demographics
Outbred adult female ferrets, approximately 8 months old.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website